Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy.
Use of combined apoptosis biomarkers for prediction of bladder cancer recurrence and mortality after radical cystectomy. Lancet Oncol. 2007 Feb; 8(2):128-36.